Trailing-twelve-month (TTM) revenue is $1.74 Billion with a year-over-year growth of +31.88%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $343,108,491 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-09-30 |
| Q4 FY2025Period ended 2025-12-31 | $354,982,240 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $395,837,800 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $649,247,244 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-26 |
| TTM revenue | $1,743,175,775 |
Current P/S: $3,997,431,350 market capitalization ÷ $1,743,175,775 TTM revenue = 2.29x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $649.25M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:24:00.739Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Others | $700,000 | $2M | $1M | $2M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| CH | $221M | N/A | N/A | N/A |
| MX | $178M | N/A | N/A | N/A |
| Other Countries | N/A | N/A |
$1.74B
$1.74 Billion
+31.88%
vs. $1.32B a year ago (TTM)
+26.38%
5 Year compound annual growth rate
1 Year
+31.88%
3 Year
+1.44%
5 Year
+26.38%
10 Year
+8.48%
15 Year
+7.26%
20 Year
+6.64%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.39B | ($169.36M) | (10.86%) |
| 2024 | $1.56B | +$38.80M | +2.55% |
| 2023 | $1.52B | +$77.00M | +5.33% |
| 2022 | $1.44B | +$823.87M | +132.98% |
| 2021 | $619.53M | ($127.82M) | (17.10%) |
| 2020 |
TTM Growth
+31.88%
3-Year CAGR
+1.44%
5-Year CAGR
+26.38%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:24:00.739Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $1.3B |
| SWITZERLAND | N/A | $243M | $264M | N/A |
|---|
| UNITED ARAB EMIRATES | N/A | N/A | $161M | N/A |
|---|
| UNITED STATES | N/A | $183M | $243M | $199M |
|---|
| $747.36M |
| +$54.75M |
| +7.90% |
| 2019 | $692.61M | +$57.24M | +9.01% |
| 2018 | $635.37M | ($21.63M) | (3.29%) |
| 2017 | $656.99M | ($23.15M) | (3.40%) |
| 2016 | $680.14M | +$139.74M | +25.86% |
